再談老人癡呆的治療-全食物療法

如何評估你的家人是否有老人癡呆?

美國華盛頓大學做了一份叫做AD8的訪談評估表:
1.判斷的能力出了問題(做決定有困難,做了坯的金錢上的決定,或者思考有問題)
2.對以往熱衷的活動或嚐好失去興趣.
3.說話一再重覆.
4.忽然對使用工具發生困難.(使用微波爐,電話,遙控器有困難)
5.忘了年月.
6.記帳報稅有困難.
7.約會的事情整個忘了.
8.每天對思想及記憶都發生問題.

得分0-1為正常.諸位朋友,如果以這個評估表來自我評估,我們都有失智的傾向了.只是程度問題而已.難怪說,失智是要經過幾十年的演化才到不能自理的地步.但如果現代人飲食不改,失智者年齡層一定會往下掉,像糖尿病患者一樣.


蘆薈多醣類複合營養品在失智上的治療成果

我以前寫過美國小兒科醫生新港瑪麗(Mary Newport)用榔子油治療她先生失智的報告.我也寫過Dr. Roy Swank 用素食治療多發性硬化症的文章.我最近看了Dr. John E. Lewis, University of Miami教授的報告,讓我感到有必要再來談論這個影響你我未來的威脅:老人癡呆的問題.
魯意斯教授 (不是醫生吧)( 精神與行為科學系),專門研究替代療法(complementary and integrative medicine).他在2013年發表一篇報告在失智期刊上( Journal of Alzheimer Disease).這篇文章引起我的注意是因為他不用藥而是用一種健康食品叫New Eden.讓37個病人吃一年,每天吃4茶匙的粉沖水或果汁喝或加在食物裡.有46%的病人對標準認知的測驗有門顯的進步.這種New Eden的補品的成份為:米糠Stabilized rice bran, 落葉松樹纖維larch tree fiber, larch tree soluble extract, 半胱胺酸cysteine, 大豆卵磷脂soy lecithin, UltraTerra* calcium alumino silicate(這是什麼?),蘆薈粉 aloe leaf powder, 櫻桃餡餅粉cherry tart powder, 肌醇六磷酸inositol hexaphosphate (IP6), 番薯粉discorea (yam) powder, omega III spherules,檸檬酸 citric acid, 葡萄糖glucosamine.我無法查到每樣的含量.魯意斯教授說是蘆薈多醣類複合營養品(aloe polymannose multinutrient complex (APMC)).但依我看就是多醣類的食物及纖維.

讓我們來探討一下.糖尿病患者無法正常新陳代謝醣類,所以我有朋友不吃米麵但其他食物照吃.雖然天天吃藥,也不夠是減緩惡化而已.但是有夠多的確據,吃全食物(蔬菜水果,全穀類,豆子堅果種子),及少吃或不吃肉(如果你吃一點肉,一定要吃"吃草"野放的牛羊豬雞)就可逆轉糖尿病2型.諸位看官,你知道嗎,吃全食物也就是吃多醣類複合營養品!!失智病人現在被稱為糖尿病第3型.如果魯意斯教授的報告屬實,那吃全食物也就能逆轉勝失智症.很可惜的,魯意斯教授知識不夠,其研究竟然沒有在全食物上下功夫.

我們知道人的第二個腦就是腸.當美國人說my gut feeling時,頗有豪氣干雲之感.當一個人肝膽相見時,說的也就是這個gut.所以無疑的,腸道的健康必能使腦健康.既第二個腦與第一個腦的健康是一致的.而全食物才能使腸健康.但全食物怎樣使身体健康呢?因為多醣的食物及多醣的纖維才能調節小腸的碳水化合物的吸收及供給細胞需要的其它營養品.(單醣食物大部份為加工食物,一下子就被腸吸收進入血液,又沒有其它營養品配合,如各種植物素)


檢討Dr. Newport用榔子油治療她先生失智

人体真的很奇妙.人体在缺少醣時,會分解脂肪來得到能量.人体在不能用醣時,一樣會分解脂肪來得到能量.分解醣需要氧,但分解脂肪就不要.但利用分解脂肪來得到能量不是常態,是一種臨時的保命措施.跑馬拉松者跑到最後上氣不接下氣,氧氣吸不上,血醣用完了,這時身體就會去分解脂肪.或者幾天沒吃東西後身體也會開始分解脂肪.新港醫生認為失智者的腦細胞死亡是因無法分解醣.但人腦如果由血液中得到一種叫做MCT ( 中鏈三酸甘油脂)的油脂,腦細胞就能分解它而得到所需的能量,腦細胞就不會死.而自然的椰子油就是這種油.所以新港醫生餵她先生每天二湯匙椰子油(混在食物裡)已有數年.她先生的惡化明顯的減慢許多,甚至逆轉.但分解脂肪而得到所需的能量終不是原始人体的設計.乃是人体一種保命的緊急機制.用久了終會失效.所以我認為新港醫生的知識也不夠,其研究竟然沒有在全食物上下功夫.

我的建議

我最近覺得我的記憶力不及從前很多,與朋友談起,很多人也都有這種感覺.有多少次你的朋友不是一再的向你訴說用一件事? 多少次你會想不起某人的名字?
不要灰心,讓我們一起來,勵行全食物(whole food)的飲食,愛己愛人.
多醣類食品以米糠,菇最多.枸杞也很多.但食物到底還是以全食物為首要.還有,不要忘了運動.每天至少30分鐘的運動做到至少微微發汗.慢跑或者快走最好.

台東的生活(2)

寧願燒盡,不願朽壞 (Rather burn out than rust out)


台東馬偕醫院
在台東時,我們每個禮拜去馬偕醫院的洗腎室幫忙二個半天.由豐里橋起,沿著北岸堤防往西走,不到十分鐘就到了馬偕醫院.一進了大門,往左看,就會看到很多人在等拿藥.每天都如此.洗腎室在六樓.我們如果是早班,由八點半到十二點,如果是下午班,由二點到五點半.做的工作:

去一樓領藥含口服藥及針劑
去二樓腎臟門診科拿估價單再拿去一樓估價再拿藥
去藥庫領洗腎室需要的補充品(大樓外面的房間及地下室餐廳旁的房間)
蓋使用截上日期在用品上
剪膠帶.每一段剪下來的其實是一個塑膠套,要將針筒塞到中間,外面再蓋品名.(這個工作污染較嚴重,因剪膠帶時會有很多塑膠屑,會污染桌子及衣褲,剪時也要帶口罩)
撕洗腎用生理鹽水的外層塑膠袋(這個工作也有污染,因要一個個撕開,可能有殘屑或氣体釋出,而且這個工作量很大,因每個病人每次都需要一袋.每一箱有二十幾袋要撕,一次要撕好幾箱,每一箱很重,搬轉困難)
偶爾推病人去坐巴士回家
偶爾幫有需要的病人登記体重
偶爾將用剩的各種不同濃度的食鹽水倒在一個桶子裡
其它一些雜事,例如中翻英,登記整理病人資料在小紙上,或幫忙推病人去急診室或回病房

這樣的工作使我們對洗腎室有一個很好的瞭解.人一開始洗腎,就年復一年的洗下去了,再也無法逆轉勝了.平常隔天洗一次,每次約洗三個小時左右.這是一個不幸的事實.
我在這數個月中,雖然知道很多病人的長相及特徵,但只結識一個病人.這位大姊年紀七十幾歲,住在池上關山地區.在洗腎的那一天,一早起來就準備來洗腎了,坐一二個小時的車到馬偕,十一點左石在醫院買一個便當吃.下午十二半以後進入洗腎室,下午開始洗腎,五點半左右下樓去坐巴士,下午七八點到家.如是的日子不知過了多少寒暑.有一天,我問她,妳洗多久了,她說不能說.她的小孩都沒跟她住在一起,倒有一個弟弟去跟她住,照顧她.她說有時身体不舒服要救護車載去附近的軍醫院急救.所以洗腎的人不止每兩天要花一天在洗腎上,而且要應付抽筋,血糖,休溫,心臟的各種突發狀況.台東馬偕醫院的洗腎病人每天約有140人左右.分三班.

我們來看看台灣的洗腎的情形.
根據陳博士的聊天室(陳俊旭)的報導:
美國2007年公布全球尿毒排行榜台灣的盛行率和發生率都是世界第一
盛行率=洗腎病患占總人口比例
發生率=每年新增加的洗腎病患占總人口比例
2007年台灣洗腎的盛行率每百萬人口1902人
2011年台灣健保每年給付洗腎費用NT308.5億
2012年全台共有6萬6千多人在洗腎

根據 The annual Fresenius Medical Care market survey 2011 年的報導:
2011年台灣洗腎的盛行率每百萬人口增加到2800人,台灣穩居世界第一名,日本為2500人 第二名,美國為2000人,第三名,第三名比第四名(1600)高很高 ( "ESRD patients in 2011, a global perspective" ) 這個數字太高,我存疑.

根據United States Renal Data System 2012的報告
台灣在2010年的發生率是每百萬人口有361人,僅次於美國的369人.(日本為288人)(台灣在2008年後的發生率突降很多,不知為什麼,更低於2001年的數據)


根據1998到2008資科,台灣人正在洗腎中平均年齡為61歲,女略多於男,一半以上有糖尿病 ( Paper report )

台東的情形:
中央健保局東區分局經理呂穎悟說台東洗腎頻率全台最高.我不知道洗腎頻率是什麼意思?大概是盛行率 ( 我也找不到台東目前有多少人洗腎,但以五家醫院,約有354人估計,台東縣有22.5萬人,這樣台東洗腎的盛行率每百萬人口1573人,比全國1902人低.所以我的估算偏低)
台東縱谷五鄉沒有洗腎中心,根據慈濟醫院的說法,是找不到專任醫師.我在台東馬偕醫院,每天病人多的不得了.每次我去領藥處領藥都要排隊.領藥處的前後台藥師個個動作都很快速.這樣的工作,除了錢較多次,其工作內涵,有趣度及成就感實比7-11的超商工作人員低.台灣這麼多病人,養了這麼多工作人員及醫院,健保不倒也困難.但護士薪水低工作忙沒人喜歡做,但錢跑去那了?台灣拚命蓋醫院,我想目前不知還有那個醫院,不向健保及病人收錢的?所謂慈善醫院,像目前的馬偕或慈濟是虧錢在做慈善,濟世活人,還是向健保要錢,全民買單?
現在的台灣已經不是台灣錢淹腳目的時代,也不是克苦耐勞,行善不欲人知的時代了.許多人浪費政府所給的福利.得到的福利沒人要減少.政府倒了,我看人民也不會後悔的.政府無能不大力提倡簡單的飲食,健康衛生的飲食,其實不是政府的問題,其實政府既代表人民. 毒澱粉,毒人工香料,毒‧蔬菜水果,毒中藥西藥,毒紙杯全部是我們同胞的傑作.台灣就是詐騙人的王國.

我們要怎麼改呢?

台東的生活(1)

退休後,你也不能每天遊玩 -豐里橋西北岸堤防草皮守護者


去台東當移民
我去年(2012)十一月過完感恩節後退休.蒙在台東大學任教的蕭老師的邀請,於十一月底,去台東當移民.今年四月中離開.以後也想如此.每年十一月到隔年的四月住在台東.在台東的日子我住在東海國宅社區.一棟四層樓高的雙拚房子.我們任在三樓.東海國宅社區附近環境优美,座落在豐里橋東南岸堤防的南面.不止社區路面整潔乾淨,附近還有一個很大的社區活動中心,活動中心不止有一大片草坪,還有黃土網球場,籃球場,室內羽毛球館及室內乒乓球館,並有一個課輔教室.每天黃昏都看到有人在那片草坪上溜狗.在太平溪河床裡也住了很多野狗.有時野狗也會跑到草坪上來.所以豐里橋的東南岸平常會見到不少野狗及家狗.住在台東的時候,我們沒有任何交通工具,充分享受二條腿走路的甘苦.在台東的日子,除了每星期有二個半天我與我太太會去台東馬偕醫院的洗腎室做義工之外,我的日子大都在台東大學,特別是在防災中心度過.我在這裡要感謝在台東大學認識的很多位老師,學生和職員,並特別感謝防災中心的王主任及同仁.他們不止讓我在防災中心有個辦公室,他們深厚的友情更讓我永難忘懷.

豐里橋
東海國宅是座落在豐里橋的東南岸的堤防旁邊.我們每天要去台東大學或馬偕醫院,會先走一段堤防,就到了中華路的豐里橋. 右轉通過豐里橋,左轉穿過中華路,再右轉前走約十分鐘就到了台東大學.如果要去馬偕醫院,我們只要沿著北岸堤防,由豐里槁往西走,約八分鍾就到了.如果要去市中心,我們會走中華路再左接正氣北路在誠品書局前方左轉穿越一小段鐵路步道就到了農會的超市.所以說我們每天都會走過豐里橋欣賞太平溪的風光.太平溪平常流量很小,但橋面很寬,我想是颱風來臨時,流量一定變大很多.在河床上平時有人放養水牛,有–些鳥又喜歡跟著水牛走動,亦步亦趨,有時也會停在牛背上,成為一幅野趣又閒適的圖畫.站在豐里橋上,往東看去看不到太平洋的.因前方尚有個外環路的混凝土橋擋住視線.但往西看去,倒可看到中央山脈.在天氣好的時候,中央山脈相當美麗.大体說來,豐里橋河床步道及河堤提供一個附近居民散步慢跑的好地方.但豐里橋本身實在不算漂亮,周圍景觀建築也不美,尤其往東北岸看去,更是礙眼.如果你沿北岸河堤往東走,約十分鐘可抵太平洋.河堤在跟外環的交叉點就斷了.這一段的河堤一點都不美.由外環路的混凝土橋到太平洋岸,更是一段非常污染的地段,入海的溪水及附近地面更有待整治.更有甚的,經中華路通過豐里橋車子又很多,所以每一次我們–走到中華路要開始過豐里橋時都要掛口罩.所以要站在豐里橋上欣賞太平溪並不是很適切.

由豐里橋到台東大學 ( 中華路的吃 )
中華路由豐里橋走到台東大學只要十分鐘就到了.但因中華路汽車及摩托車很多,路旁也停了很多車,又加上我走路喜歡看東看西,這一小段中華路走起來就蠻有挑戰性的.這一小段路開有不少商店.有–些店給我的印象很深刻.這一小段路共有三間檳榔攤.檳榔攤在台東市有很多,台東有很多人嚼檳榔.據說吃檳榔,飽後食會消,飢前食會飽,醒時吃會醺,醉後吃會醒.如果不以健康來考量的話,檳榔想必很好吃,林光中曾撰文讚美檳榔的美味.但吃檳榔抽香煙及喝洒對身体健康最傷.檳榔這行業是全台單一宗最大的農業.但吃檳榔引起的醫護成本也可能是最大的.我觀察每間店,店內平常都會有一個婦人坐在一張桌子上,不停的在包檳榔.顧客會開車或騎摩托車來購買.這三間生意都非常好.台灣要健康,我們要在檳榔的栽種,行銷多加研究外,並要對上癮者如何戒除上有鼓勵及有醫療所.政府更要對轉耕者輔導.這段路有一間台東有很多分店的糕餅店希拉蕊.希拉蕊的西點是標準的台式西點,麵包鬆軟,比較甜也比較油.我並不喜歡.但這種台式糕點全台皆是.我們在台東較常去的糕餅店叫牧心.這間店的西式麵包較合我們的口味,也較合我們的健康原則.在正氣北路跟中華路的交叉口上有一間店很小但生意很不錯的烤鴨店.這個烤鴨店有二個人在經營,中午的時候經常看到他們坐在狹窄的店內用餐.門口有二個烤爐,早上他們會放鴨子進去烤,因為時間不對我尚沒有聞過烤鴨的味道.也尚沒有机會品嘗.由外觀看來這裡的烤鴨跟廣式的烤鴨是不一樣的.這一段路又有一間很有名氣的池上便當店.聽說他們的招牌便當最有名.我在台東吃過幾次便當,也吃過二次這間的便當.但我並沒有感到特別好吃.因我不喜歡飯被壓在便當盒裡,吃起來黏黏的不冷不熱的感覺.這段路有一間叫做不喝不行的快炒店,晚上經常高朋滿座.但可惜的在對街,不喝不行店貼有一則不得在此嘔吐的廣告.因為這個不喝不行的店名及不得在此嘔吐的標示,我對這間店印象特別深.在靠近台東大學的右側路邊,在今年初停靠了一輛機動早餐車.賣的是蛋餅,飯糰之類的早餐.東西就統統放在一部發財車上面.我每天早上約八點出頭去台東大學的途中會經過那裡,每次見面我們會彼此問安.有一次他告訴我,他每天早上三四點就要起來準備食物.早餐賣完就沒有再做其它的事.雇請–個幫手有困難.因要早起,事忙而且每天只有幾個鍾頭.工資又沒法給高(大概100元一個鍾頭).在這簡短的對談中使我明白升斗小民的打拚及生活的不易.在這小小的一小段路,尚有許多生意很好的店,例如有間生意很好的煎包店,看起來很好吃,但我又覺得油太多 ,所以尚沒有勇氣嘗試.我這裡要特別提到一間賣蔥油鉼,鹹甜燒餅的小攤.這個攤子並不在中華路上,但在中華路及正氣北路交口往西走的二十公尺左邊路邊的正氣北路上.是一擁路邊粗糙簡陋的似攤非攤的小店.趕麵烘烤都在那露天轉角倣.兒子是老板,母親是師父.每天下午四點左右開始烘烤,物美价廉,有時要排隊但有時排到隊時已缺貨.老板給我的名片並不是賣蔥油餅的,而是經營健康營養品的.可見台東人的機動性及勤勞刻苦.


台東大學,台東大學的防災中心
台東大學在台東市的校區,處於体肓館,鐵花村及舊火車沾的旁邊,隔著中華路與台東中學相望.是台東市人文及教肓的火車頭.校區建築雖平常,但校園種有很多樹,其中有百年老榕.整体說來,給人一種閒適怡人的感覺.我每天最喜歡的一段步行是由中華路切入教育大樓,再順著前面的路,經辦公大樓旁的林蔭小徑,穿過排球場的右邊走到防災中心及創新育成心這一段.
我在台東的時候,防災中心正在進行台東農村再生計劃.他們要幫助山區裡的部落或村莊做農村再生及文化保存.他們帶我到山區幾次.北到泰原的山裡,南到嘉蘭大烏大武.台東的山區很漂亮,但要發展山地村落的經濟很難.主要是山裡除了美麗的山色及寧靜的生活之外沒什麼活動可吸引人.休閒的步道少,美而廉又俱備原住民的民宿及飯店缺少.溪水遠看雖美,但大半無法泛舟溯溪.山區騎腳踏車有安全問題.我們所到的一些地方看不到有給路過的人食宿的地方.過客停車下來,也不知要倣些什麼.我建議山村可利用學校試辦一些露營及生態体驗營看看.或者利用住家多出的房間辦過夜兼早餐的小民宿.至於農業,山區可考慮發展精緻或有機農業.

台東大學,台東大學的有機店及有機農夫市集
台東有很多有機店,但影響我們生活最深的就是台東大學的有機店. 台東大學的有機店,就在創新育成中心及防災中心的樓下.歸創新育成中心管理.這個有機店每天營業.而且每個禮拜天早晨有有機市集. 這個市集就在中華路上的人行道旁開賣.約有十多家有機農夫參加.這家有機店是我太太的最愛.幾乎每個禮拜她都會去.她跟店裡的工讀生及經理很熟並成為朋友.台東大學的有機市集我們較少去,因為是禮拜天而不是禮拜六.大部份的農夫,禮拜六會在另一個地方,介於農會超市及麥當勞及停車場之間的的一長型空地擺攤(南京路跟新生路的交口).這個市集是我們去聖母健康會館吃中飯時都會從那裡經過.所以後來我們禮拜六就會去那個市集逛.我們跟這些台東種有機的農夫慢慢相熟.後來跟一位住在大武山豬窟山上經營有機活泉農場的農夫林木泉交往進而成為好友.這些有機農大部份規模不大,要得到有機認證不容易.林先生生活簡樸,篤信基督,一個人住在山上,天未亮就起身做工,深夜讀經禱告,幾近餐風露宿,靠二隻土黑狗倣伴.田地要靠有機肥慢慢改變土質,數年來尚無法收支平衡.他每禮拜六早上要由大武山上開車到農會前擺攤.過完午,休息一下,下午到晚上在鐵花村的夜市續攤,禮拜天–早再到台東大學的市集.他是以傳教士的精神在經營有機農場.他是在幫助顧客,教肓他們跟他們做朋友多於做生意.聽說他有數個死忠的粉絲.我另外認識一位相當熱心,在台東大學有機市集倣義工的周女士.這個市集雖然只有十幾家,而且每禮拜只有禮拜天早上開市,卻有二位義工.這二位義工都是已經退休的女士.他們每個禮拜天早晨來此幫忙.周女士一直遊說我也去做義工,但因我們禮拜天要去教堂,只能婉拒.

台東地方特別,山水天然未被過度開發,污染少,而且花東縱谷非常漂亮,人民淳樸,過簡單的生活.海岸線雖長但沒有良好的港口,也沒有良好的沙灘.原住民多,,山地農村再生困難,而且很多人有抽煙喝酒嚼檳榔的習慣.台東縣這幾年來總人口負成長(1998年底由24萬8千到2011年底的22萬8千),但老年人口卻增加(86年底由2萬7千到95年底的2萬9千),人民謀生不易. 台東市與西岸交通不便.台東只有一所大學,這個台東大學實為台東之寶.但很可惜,這個大學看起來就像一個普通的大學,並不是一個俱有台東特色的大學.

所以台東大學要成為一個具有地方特色的大學,要培養人才來經營台東特有的山水.不止要增加台東當地的就業的機會,同時也要有永續經營的理念.台東大學的劉院長在深層海水利用,有機農業推廣及河川整治已有頗具前瞻性的推廣及發展.防災中心的王主任在台束防災及農村再生上也做了很多事倩,今就我所知及觀察,再補充一二.

第一,我期望台東大學可在檳榔的研究上大力發展,成立檳榔研究中心.
我剛抵台東不久,就感受到台東很多人吃檳榔.短短的一小段中華路,由豐里槁到台東大學就有三家檳榔攤.火車由大武進入台東市,沿途就看到左邊的山腰種了很多檳榔樹.在靠近鐵道兩旁,也看到有些用黑色塑膠布蓋住的農田.後來友人告訴我這些是種荖葉.荖葉,荖花是吃檳榔不可不有的配件.檳榔這個農產品已經是全台最大宗的農產品.超過稻米的產銷,全台產殖每年上百億.種檳榔破坯山林水土保持,吃檳榔增加口腔癌的機會,隨地吐渣影響環境衛生.但吃檳榔的人數卻有增無減.很多台東人靠檳榔為生.(全台種稙檳榔最大的縣是屏東而不是台東)但在這種環境下,台灣各級政府對這種影響環境及國人健康這麼嚴重的議題採取不聞不問及不管的態度.我深信我們要製訂良好的管理政策,禁止增種檳榔,禁止進口檳榔,宣導進食檳榔的壞處,成立檳榔戒食中心,輔導轉種他種作物,以及其它措施.這些都是檳榔研究中心可以做的事.

第二,我期望台東大學可在海洋的研究上大力發展,成立海洋或黑潮研究中心或者治海系.
如果你去過台東海岸,你就知這台東的海很奇特,海岸大都是岩岸,沿著海岸往外看,海水有三層顏色,靠近海岸是淺夾色,再來是一層深黑色,即是黑潮,最外面才是平常籃色的海.初看並不怎樣,但久看就有一種天然的粗糙美.台東東岸有很長的海岸線,台東是發展淺海養殖,近海遊憩,黑潮研究,海浪發電的絕佳所在.但台東大學連一艘船都沒有,實有待急起直追.不然鬼頭刀,旗點追飛魚,鮪魚追鬼頭刀旗魚的美景生態將一去不復.

第三,我期望台東大學可在山地的研究上大力發展,成立治山研究中心或治山系.
台東人說台東是台灣的後山,台東的朋友也都自豪的說台東有好山好水.台東碓實有好多山村,但可惜山地人口外流,人民謀生不易.台東因為是台灣的後山,住在山前的台灣人就比較不管後山的需要了.但到底後山人的需要是什麼呢?是熱氣球嗎?是杉原溪的美麗灣大酒店嗎?
如何經營台東特有的山林河流.颱風如何預測防治.山林疾病如何預防,山區動植物如何管理增生,山區部落如何再生管理.有機小農如何輔導,經營,產銷,小農如何共生合作防止大財團併購等都是治山研究中心的好題目

我知道台東大學要全部搬去知本了.我去知本校區看了一下,很失望.整個校園的規劃及建築沒有綠建築的觀念.沒有太陽能發電,建築沒有運用綠建築的觀念,沒有電動機車优先停車站電動車充電站.水資源也沒規劃.學校外面就只有一條筆直的馬路,完全看不出對新校區週圍馬路及公共社區的規劃及營建.如此大學生活,如何營育俱前瞻性看法的學生?而且台東市一旦失去台東大學,將會是一個怎樣的城市呢?台東大學搬家的主因聽說是為將來的發展考量.但想想看,台灣及台東的人口一直在減少,大學又那麼多,政府又欠了那麼多錢,我認為台東大學在現有的台東市校區發展就夠了.不知我的呼籲是否太遲了?我想目前全校教職員不會搬去知本的居多,而由台東知本來回要四十分左右,浪費大家的時間及汽油費及增加空氣的污染.我想學生大部份也可能不會搬去,因為知本校區附近沒有文化及休間的設備.長遠的來說,以目前政府的財力,要在知本再造一個新鎮是遙不可及的.

我盼望台東好,台東大學對台東的特色:"山林海域及特殊的人文"有直接及深遠的貢獻.

增強免役力治癌(Immunotherapy to treat cancer)

癌症的西醫療法
手術,化療及放射療法是現今醫界最常見的.
Immunotherapy,事實上不能翻成增強免役力,而是一種特別的免役力治癌法.

癌症是免役力出問題嗎?
我們都知道癌症致病有很多原因.環境,飲食,人承受的壓力,以及遺傳.但是這與免役力有關嗎？我們聽到的理論,有一種是說人每個人每時刻身体都會產生癌細胞.但身体的免役細胞會自己來清理.這個理論有二點不完全.第一:是什麼機制,使身体自動產生癌細胞的? 第二:我們看到許多得癌症的人,身体都很健康的時候發病,為什麼?
抽煙會致癌,這是因為污染物進入肺部.大吃肉食會得大腸癌這是因為肉食會在腸內腐敗生致癌物.皮膚癌是因為曬太陽.但乳癌,卵巢癌是荷爾蒙失調,攝護腺癌呢是肉食太多.如果用一句話來描寫,是生存環境惡化,人為了生存,以為增生癌細跑就可繼續存活.如果你們有種菜的經驗就可了解我的說法了.如果乾旱,雨水不調土壤貧瘜,種的蔬菜會很小,但開花結子很多.這樣,身体免役力就不會認為癌細胞是敵人.這是我解釋癌發生的原因了.免役力是可以殺癌細胞.但當身体在太惡劣的環境下,免役力就失去了它的功能.(身体有時也不一定非把癌細胞殺死,只把它包住就可了,見李豐:我賺了三十年),身体會想增生癌細胞來對抗惡劣的環境.所以對抗癌第一要免除惡劣的環境,第二要增強免役力.

如何叫免役力細胞去殺癌
根據西方醫學的研究,目前最夯的就是驅馳免役細胞去殺癌細胞.但我們不是說在体內環境很惡劣的時候,身体會產生大量的癌細胞來逃生嗎?是的,此時免役力細胞的外部的一種蛋白質會叫免役細胞不要動手.這種蛋白質的作用就是節制免役細胞.目前的研究就是發展出一種藥來跟這蛋白質結合,如此,免役細胞就不再節制,就會去攻擊癌細胞及身体各處的非癌細胞.這種藥在美國已在賣了,藥名叫YERVOY.YERVOY是用在皮膚癌(malignant melanoma)已擴散的病人身上.大部份可延長壽命,小部份可完全治癒.這種新的免役療法其負作用像免役力失調,全身都會被攻擊.但已擴散的皮膚癌几乎都沒救了,所以這個方法很受歡迎.但是這是欺騙身体的做法,殺傷力很大.現在這個方法會被用在一些已擴散的非皮膚癌的治療上.


利用真正的免役力治癌 strong immune system is the king
關於免役力,我想大家都聽很多了,我們知道身体免役力高,就不容易生病.免役力低就容易得感冒或生其它的病.有些病是免役力失常,例如異位性皮膚炎或者是狼瘡.但一般尚沒有人會認為得糖尿病高血壓是因為免役力低的.糖尿病高血壓被視為一種新陳代謝出問題的疾病,與免役力高低無關.但事實上有糖尿病的人其得癌率高於一般人高(9%),而且死於癌症的比率也比一般人高(11%).至於有高血壓的患者呢?其死於癌症的比率比一般人高(24%),其得癌比一般人高(29%).有糖尿及高血壓的患者生其它病的機率是比一般人高的.我想這也應與免役力低有關.所以真正要治第一:去除惡劣的生活環境.第二:增加免役力.惡劣的生活環境不去或不改善,免役力會無可奈何.

增加免役力的方法
方法很多,但飲食要先以無毒的蔬菜五穀為主,再加上無毒的水果及堅果種子.紅肉致癌,魚肉含重金屬,放療本身致癌及長期肌肉骨頭受損,你該知道怎麼倣吧!!



http://www.cancer.gov/researchandfunding/extramural/cancercenters/accomplishments/yervoy

冷療治癌 ( cryoablation for cancer treatment )

什麼叫做冷療治癌
把細胞冰死的方法叫冷療.以一個探針插入腫瘤的中心,讓針頭形或一個冰球溫度達到攝氏負一百七十度左右來冰凍癌細胞.一般用氬氣.十分鐘後用氦氣來解凍.然後再用氬氣來冰凍一次,總共約三十分鐘.只要局部麻醉,當天或隔天就可出院.導管是中空的絕熱管.利用超音波或MRI定位.

應用
攝護腺癌 (在美國已非常普遍.但操作方法與上述略有不同,一次約美金一萬三千元左右,可重複做.)
擴散的肝肺卵巢大腸或腎的腫瘤.(Peter Littrup and Hyun bang of Wayne State Univerity of Michigan, 他們有超過一千次的經驗,便宜而且效果又好又不痛,一次約一萬五千元.)
乳癌 ( 數個美國大型教學醫院已做完27個病人的臨床研究第一期.這些實驗的病人是在幾個禮拜之後再做部份切除術時量測癌胞.結果是腫瘤小於1公分或者腫瘤如果是浸潤性導管癌,小於1.5公分其去除率百分百.目前正做第二期.冷療在乳癌上的治癌最讓人興奮.不止無痛,乳部保留,低價,而且不必化療或放療.而且可重復做,因為凍死的癌細胞被人体的清道夫細胞吃掉後讓身体的免役力變強,不易復發.同時在冰凍時癌細跑沒機會逃走,所以也不會轉移.以後只要身心靈保持健康体內排毒乾淨應可保安康.根據資料美國已有診所在做乳癌的泠療.例如Dr. Simmons:
Dr. Rache Simmons
NewYork-Presbyterian / Weill Cornell
425 E 61st St
Fl 10
New York, NY 10065

在英國奧地利及中國也都有醫院在做冷療.台灣呢?

我的意見
因為探針小,冰球成形就不會太大.這是為什麼美國臨床只用在小於1.5公分的浸潤性導管癌的原因.但我們可一次用兩個或兩個以上的探針呀?或者用單一探針但移位使用像在做採樣本的做法.這樣較大的腫瘤也可治療了.中國福大(Fuda)醫院用在無法再開刀的病人上也取得相當的成績.原位癌若怕無法殺死全部,似乎也可重複做呀,而且若免役力增強說不定清不乾淨的癌細胞最終也會被殺死.所以我覺得冷療的應用在乳癌的治療上實值得台灣急起直追.希望全台的乳癌患者團結起來去總統府前抗議示威要求台灣應在冷療及低電流療上好好研究及應用,去除不人道的程咬金的三斧頭:動刀,放療及化療.




Read more: http://www.vitals.com/doctors/Dr_Rache_Simmons.html#ixzz2Qo3s9bb7)


Dr. Peter Littrup, a professor of Radiology, Urology and Radiation Oncology Clinical Operations at the Barbara Ann Karmanos Cancer Institute in Detroit
http://www.knowcancer.com/blog/ice-age-cryotherapy-may-be-the-future-of-cancer-treatment/

Cryosurgery of breast cancer by Lizhi Niu1,2, Liang Zhou1,2, Kecheng Xu1,2
Aug 10, 2012, Gland Surgery
http://www.glandsurgery.org/article/view/992/1195

1Department of Oncology, Affiliated Fuda Hospital, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Science, No. 91-93 Judezhong Road, Haizhu District, Guangzhou 510305, China; 2Guangzhou Fuda Cancer Hospital, Jinan University School of Medicine, No. 2 Tangdexi Road, Tianhe District, Guangzhou 510305, China

Corresponding to:
Lizhi Niu, MD, PhD. Guangzhou Fuda Cancer Hospital, Jinan University School of Medicine, No. 2 Tangdexi Road, Tianhe District, Guangzhou 510305, China.
Email: niuboshi1966@yahoo.com.cn.

Patient selection of cryoablation

Patient selection is key to successful cryoablation. DCIS represents a special problem, the presence of DCIS at the margin of the cryoablation zone results in incomplete tumor necrosis, in other words, DCIS may be a relative contraindication to cryotherapy. However, even using MR imaging, DCIS lesions are only detected in 60-70% of patients with breast cancer (15). This fact makes it impossible to include DCIS components of invasive carcinomas in the therapy planning for such cases.

Generally, DCIS is often seen in tumors >15 mm. Cryoablation is adaptable for tumors <10 mm, for primary tumors 10 to 15 mm, only those without an extensive intraductal component are destroyed, while tumors over 15 mm are not reliably eradicated with cryoablation.

Core biopsy is helpful to detect the presence of DCIS. Specifically, the noncalcified type of DCIS causes the most treatment failures in the patients with larger tumors. It is suggested that cryosurgery should be limited to invasive ductal cancers <1.5 cm and with <25% DCIS on the core biopsy. Some breast cancers, such as invasive lobular carcinoma and significant intraductal carcinoma, tend to be multifocal and may include foci too small to be detected through imaging, making them unsuitable for in situ ablation. Tumors that present with more than the most minimal degree of microcalcification should also be excluded, since the extent of these lesions on mammography often can not be detected (5).

It is suggested that the immune system of the host becomes sensitized to the tumor being destroyed by the cryosurgery. As the body resorbs the necrotic tissue, an active immunity is developed for the tumor tissue. Any primary tumor tissue undamaged by the cryosurgery and the metastases can be destroyed by the immune system after cryosurgery (32,33). The “cryoimmunological response”, obviously, results in therapeutic benefits for advanced breast cancer.

http://www.fudahospital.com/alb_asp_new/show_crosurgery_book.asp?page=crosurgery_2_5_1

Dr. Michael Sabel, surgical oncologist from the Comprehensive Cancer Center and lead author of the study, University of Michigan
http://www.ur.umich.edu/0304/May24_04/19.shtml
Funding for the study came from Sanarus Medical Inc., which developed the cryoablation probe used in the study.



Oxford University Press
http://jnci.oxfordjournals.org/content/92/18/1464.long

Nikolai N. KORPAN, MD, PhD, FISS, FICS, FISC
University Professor of Surgery
General Practitioner Surgeon
The Rudolfinerhaus
Billrothstrasse 78
A-1190 Vienna, Austria


the modern cryosurgical unit ,,FreezeForce1" is a highly sophisticated Universal Cryosurgical System developed to meet the most demanding needs of today's "White Surgery

At present only a handful of companies are in the cryosurgical market. These include Irvine, Calif.-based Endocare Inc., Galil Medical Ltd. of Israel, and Cryomedical Sciences Inc. of Rockville, Md

低電流治癌

我最近在網上看到台灣出了一個性學專家叫林坤地(他是柏克來大學的博士)的文章.當然了,這篇文章是為了他的情趣商品打廣告.但引起我興趣的是,他文中提到他看了Robert Becker "Body Electric"給他的影響.
這就引起我的興趣來了.所以我就上去買了Robert Becker的書來看.一看之下讓我十分著迷.Robert提到用極低直流電流讓骨頭再生及消毒的詳細經驗及觀察所得.書中也提到低直流電對治癌腫的介紹.這就更引起的更大的興趣了.
我於是再去追讀Dr. Nordestrom 及 George O'Clock的網上書(目前才讀幾頁)及其它報導.以下是我的綜合報導.
1.用低電流(MA milliamper 或者NA nano ampere )治癌腫瘤是可行可靠以及高治癒率.可比美化療放療及手術.
2.可內插探針,一極在腫瘤上,或者二極橫跨腫瘤二側.
3.如單極,則正頁極皆可.
4.內插極針以銀針最好.
5.銀離子本身能讓癌細胞變成正常的細胞.
6.也可用外接電極版不侵害腫癌.此方法更簡單可行.
7.也可用高頻交流電.此方法在美國已有得FDA批准用在治療後發性的腦癌.
8.中國以曾幼林(北京中日友誼醫院)臨床實用為主有成千上萬的統計資料可供參考.Nodestrom醫生 將低電流治癌方法引進中國,而由曾幼林醫生發揚光大.曾幼林醫生是針灸大師曾式範針灸痲醉動剖肚手術.但可惜我尚無法找到曾醫生的中英文文章閱讀.
9. 美國廣播界名人Barbara Wakter曾為低電流治癌報播過一個專題.
10.目前也有利用低電流流經癌腫會與正常細胞不同反應原理製成手提的癌腫探測器.
11. 可以DIY 治癌用TENS嗎?應該是一個很有趣的研究.我的gut feeling is YES!!
12.一套TENS也不夠是美金一百出頭.
祝大家身体健康.



The Body Electric By Robert Becker and Gary Selden Harper 1985

可網上閱讀或 Free download:
Electrotherapeutic Devices: Principles, Design, and Applications By George D O'Clock Artech House 2007

eBay 或 Amazon 有賣但太貴 但可Google book search on line read
Biologically Closed Electric Circuits (BCEC)
CLINICAL, EXPERIMENTAL AND THEORETICAL EVIDENCE FOR AN ADDITIONAL CIRCULATORY SYSTEM By Björn E W Nordenström, M.D., Professor Emeritus of Diagnostic Radiology,Karolinska Institute and Hospital, Stockholm, Sweden 1983

利用低電流 ( 未知？) ( 電壓20V - 25 V ? )高頻交流(100kHz 200-kHz) 外接探針原理
The NovoTTF is a six-pound device that patients carry with them in a small bag. The electrical current is sent from the device to four electrodes which are attached to the patient's shaved head. reported by Matthew Perrone of HuffintonPost, 04/15/2011
The man behind Novocure is Yoram Palti M.D., Ph.D
Yoram Palti, of the Technion–Israel Institute of Technology in Haifa, and his
colleagues have demonstrated another way to disrupt cell division: alternating
electric fields with intensities of just 1–2 V/cm. The fields they use, with
frequencies in the hundreds of kilohertz, were previously thought to do nothing
significant to living cells other than heating them. But Palti and colleagues
have conducted a small clinical trial showing that the fields have an effect in
slowing the growth of tumors.
These special fields alter the tumor
cell polarity at an intermediate frequency (on the order of 100-300 kHz). The
frequency used for a particular treatment is specific to the cell type being treated (e.g.,200kHz for GBM).

At one-second intervals, the field orientation switched between front to back and
side to side, so that the field would have the greatest effect on tumor cells
dividing in all directions. Patients wore the electrodes 18 hours per day for up
to 18 months.



利用低直流電流( 100 - 200 nano amper per center meter of electrode ) 低電壓 ( < 10 v) 內扎探針 ( electrode can be silver )
Robert Becker

Luca Cucullo, Damir Janigro, and their colleagues at
the Cleveland Clinic have found that low-intensity alternating current with a
much lower frequency—about 50 Hz—can keep some types of cells from dividing.3
類似Robert Becker 實驗

Radiofrequency Therapy (RFT)
Dr Ahmed Sarwar Morshed is using most modern radiofrequency generator and the Leveen needle electrode, produced by Boston Scientific, an internationally reputed organization of the US and approved by the US Food and Drug Administration, for the treatment of cancer patients.at the Gastroliver Hospital in Bangladesh reported by BSS.
It is a high frequency AC current which stimulates the elements of tumour cells by entering into them and the temperature of the tumour climbs to 60 degrees Celsius after the heat is produced due to friction of the elements," he said.

http://www.dragonfly75.com/eng/research.html#3

http://www.healingcancernaturally.com/greatesthits4.html

ADELAIDE, Australia (Reuters Health) - Surgeons here who pioneered the use of electrical current to destroy liver tumours say they are optimistic that the treatment could be used for tumours of the pancreas and kidney as well. The treatment, called electrolysis, involves placing electrodes into liver tumours and surrounding tissue. A small electric current is then passed through the electrodes to destroy the tissue. In some cases, affected parts of the liver are removed surgically.
The leader of the surgical team investigating the treatment, Professor Guy Maddern of Adelaide University, told Reuters Health that the method causes a change in the acidity of the tissue and "poisons the tumour."
"It is less destructive than surgical removal of the tumour, and can be used to treat tumours that are awkwardly located, such as next to large blood vessels," he added. Maddern and his colleagues have treated 10 patients, with follow-up ranging from 6 to 43 months. Nine of the patients had bowel cancer that had spread to the liver, and one had cancer that originated in the liver.
In order to be included in the study, patients had to have no other untreatable tumour outside the liver, and to be fit for major surgery. All patients, said Maddern, had extensive disease in the liver.
Eight of the patients show no evidence of residual tumour at the treatment site. Five of these eight patients have developed new areas of tumour spread, while three have no evidence of new cancer growth.
"In any case, after surgical intervention without electrolysis, 60% of patients would be expected to develop new disease," Maddern said. "We are trying to increase the percent who don't get new disease."
When added to surgery to remove a tumour, Maddern noted, electrolysis increased the percentage of patients who were treatable with surgery from 20% to 25%. "We have been developing this technique for 5 years. We are now ready to move forward and are considering tumours of the pancreas and kidney," Maddern told Reuters Health. "They will be the next step."

Professor Guy Maddern
MBBS PhD MS MD FRACS
RP Jepson Professor of Surgery; Head of Discipline
Contact details
Discipline of Surgery
Level 6A, Main Building
The Queen Elizabeth Hospital
Ph: +61 (0)8 8222 6756
Fax: +61 (0)8 8222 6028
Email: guy.maddern@adelaide.edu.au
Biography
• Head, Discipline of Surgery, University of Adelaide
• Interim Head, School of Medicine, University of Adelaide
• Director, Division of Surgery, The Queen Elizabeth Hospital
• Director, Basil Hetzel Institute, The Queen Elizabeth Hospital
• Surgical Director, Australian Safety and Efficacy Register of New Interventional Procedures - Surgical (ASERNIP-S)
• Surgical Director, Country Health SA

Clinical interests
• Hepatobiliary surgery
• Colorectal hepatic metastatic disease
• Minimally invasive surgery

Research interests
• Development of techniques for liver tumour destruction (particularly minimally invasive techniques capable of destroying both primary and secondary liver tumours by the insertion of electrodes)

Current research offers hope for liver cancer patients


Professor Guy Maddern.
Full Image (698.9K)



Two electrodes are used to treat a tumour in the left lobe of a patient's liver. Gas from the electrolysis forms a cluster of bubbles around one electrode. The yellow structure is the divided ligamentum teres. Photo: Dr Guy Finch.
Full Image (259.63K)



Darkened liver tissue surrounding the large electrode has been destroyed by electrolysis. A smaller probe below it monitors the pH (acid/alkali) changes within the tissue.
Full Image (370.89K)

Friday, 30 June 2000
Cancers of the colon and rectum are among the most common. While early diagnosis offers good prospects for their treatment, many are diagnosed at a late stage. By then, a colo-rectal cancer which is in itself treatable has often spread to the liver.

Cancers of the liver are generally incurable. Only about 20% of livers diseased with tumours can be treated at present, and even then only with difficulty. Because the liver is essential for life and health, surgery is impossible when it involves the removal of excessive amounts of liver tissue. Transplants usually can not be considered.

A medical research team from Adelaide University has begun final trials on a new and promising treatment for these liver tumours. The surgeons, based in the Department of Surgery at Adelaide's Queen Elizabeth Hospital, are now tackling liver tumours with electrolysis.

Electrolysis involves passing an electric current through the liver, a process that produces chemical and physical changes. Electrolysis can split water into oxygen and hydrogen, or produce strong acids and alkalis from neutral solutions.

The surgical team has developed techniques for inserting electrodes into a liver tumour and using low voltage to move ions between them, liberating toxic substances that destroy the tumour chemically. The current can be controlled to deliver a predictable dose-dependent response over time, and even very large tumours can be treated.

"The tumour isn't burned,' explained Research Assistant Ms Paula Baxter, 'the current is too low. We have an apparently safe process of destroying the tumour with the chemical action of electrolysis."

The technology has been developed conjointly with the University of Leicester. Over the last 4 years, 5 doctors from Leicester have been collaborating with the Adelaide team, led by Professor Guy Maddern.

"This is a technique and a technology that has not been used anywhere else in the world for this sort of condition," said Professor Maddern. "It is now being published in recognised journals and we hope that if we can get it working efficiently, it will be picked up around the world," he said.

"By placing the electrodes very carefully into the tumour, we hope to treat patients without resorting to major surgery,' said Dr Guy Finch. 'We might even see the day when electrodes are left in the liver for several weeks, and patients come into the clinic for several sessions of treatment until the tumour is destroyed. It would be simple to manage, causing little discomfort and minimal disruption to patients' daily lives," he said.

Following initial work on animals, a pilot study on five patients showed complete tumour destruction in all cases. That trial led to the use of electrolysis to treat three further patients with inoperable liver tumours. A surgical procedure on one patient 12 months later showed no trace of the original tumour, and that patient is now at 20 months follow up. The other two patients are currently at 14 and 12 months follow up, and neither shows any evidence of liver tumours.

"The patients we've treated to date have all gone well," said Professor Maddern. "They continue to be so, and some of them are now alive and well at a period of time greater than twelve months," he said.

"I think that this is not going to be a cure-all for all people," said Professor Maddern, "but I think for those who have cancers in the liver that are considered to be inoperable, this makes the patients potentially operable," he said.

"If in the future the disease returns, after what we thought was a curative operation, we may well be able to treat these patients without the need for surgery," said Professor Maddern. "We expect that the technique will improve a lot over the next 12 months."

For any new form of cancer therapy to become accepted in clinical practice, it must be shown to improve patient survival. This is best shown by a 5-year follow up of a controlled clinical trial of patients with inoperable disease.

The Department of Surgery is very keen to have any patients with known liver cancers referred to them to be assessed for their suitability for electrolytic treatment.

Arrangements can be made directly with Professor Maddern's receptionist at the Queen Elizabeth Hospital ph (08) 8222 6750.

Bimodal electric tissue ablation: positive electrode studies
C Dobbins
C Brennan
S A. Wemyys-Holden
J Cockburn
Guy Maddern, Government of South Australia, SA Health
Abstract
Background: Bimodal electric tissue ablation is a novel variation to standard radiofrequency ablation that produces significantly larger ablations by the addition of a direct electrical current. The negative electrode is attached to the radiofrequency current and the positive electrode is placed nearby. It has been identified that an electrolytic injury can occur at the positive electrode site. It is suggested that by increasing the surface area that is in contact with the positive electrode, the risk of tissue injury is reduced. This hypothesis was tested in a pig model. Methods: Thirty-six ablations were carried out in the livers of six pigs (six ablations per pig). Two were standard radiofrequency ablation controls and two were carried out with positive electrode attached to a scalpel blade. Two were carried out with positive electrode attached to a grounding pad. After 48 h, liver was harvested and the ablation sizes were compared. Skin biopsies were taken from the scalpel site and one from the pad site and examined histopathologically. Results: The scalpel blade ablations were significantly larger than controls and the grounding pad ablations (P < 0.001). The grounding pad ablation was significantly larger than controls. The scalpel blade skin site showed full-thickness tissue injury. The grounding pad site appeared microscopically normal. Conclusion: By increasing the surface area that connects to the positive electrode, significantly larger ablations can be carried out while minimizing the risk of associated tissue injury.

Alternating current electrical stimulation enhanced chemotherapy: a novel strategy to bypass multidrug resistance in tumor cells

Parallel cultures were exposed for 3 hours to increasing concentrations (1, 2, 4, and 8 microM) of doxorubicin following stimulation to 50 Hz AC (7.5 microA)


Damir Janigro1,3,4, Catalin Perju1, Vincent Fazio1, Kerri Hallene1, Gabriele Dini1, Mukesh K Agarwal2 and Luca Cucullo1*

Dr. Robert Beck's product
http://shop.toolsforhealing.com/category_s/1.htm?gclid=CKfTgZi-3bMCFXCmPAodw3IAZg

利用電位測乳癌利用共振原理殺乳癌

http://www.breastcancerinitiative.com/

Our Mission

BreastCancerInitiative.com is focused on the development of a new method for detecting and treating breast cancer. Our core technology uses a single and relatively simple non-invasive device that initially operates in its detection mode to locate the breast cancer and then, using a critical part of the information provided in this process, switches to its therapeutic mode to eradicate the cancer.

Breast Cancer Screening

X-ray mammography is the "gold standard" for breast cancer screening. Mammography accounts for a reduction in breast cancer mortality of about 20%-30% for women of age 50-69, and of about 17% in women of age 40-49.

Limitations of Mammography

Mammography fails to detect 1 of 6 breast cancers. Furthermore, when the mammogram is read as suspicious of cancer, follow-up breast biopsy does not show a cancer in 80% of these patients, causing unnecessary stress and expense. In addition, the breast compression required to produce a good mammographic image can be painful, and there is exposure to small levels of X-ray radiation.

The National Cancer Institute, setting a balance between benefits and risks, recommends that women age 40 and older should have mammograms every 1 to 2 years.

Treating Breast Cancer

Cancer is characterized by a significant increase of cell division compared to that of normal tissue. This difference in the rate of division is the basis of current methods of treating cancer. High energy radiation and many chemotherapy drugs work by interfering with the cell division cycle. Unfortunately, some types of healthy cells divide as rapidly as cancer cells and are badly damaged as well. Such cells are found in bone marrow, the lining of the digestive tract, reproductive organs, and hair follicles. Some significant side effects of chemotherapy or irradiation is hair loss, anemia, and susceptibility to infection. The damage to healthy cells limits the extent of radiation or the drug dose and therefore limits the effectiveness of these treatments.

Our Core Technology

Current within tissue is due to the movement of ions. The opposition to this movement is called electrical bioimpedance. Our core technology is based on changes in bioimpedance characteristics of tissue that have been documented to occur when normal tissue undergoes malignant change. These changes serve as a marker for the presence of cancer.

BCI Breast Cancer Detection

Electrical bioimpedance is measured by applying a very small, imperceptible current between any two electrodes of a breast electrode array, for example, as developed previously by our group and shown to the right.

Our innovative technology has advanced, and we can now measure electrical bioimpedance with previously unattainable detail and precision to produce a 3-dimensional breast image such as illustrated right. The diagnostic accuracy of our new, patent-pending technology has the potential to equal or exceed that of digital mammography. A sample output, obtained from a patient with a malignant breast tumor is shown, with normal breast color-coded yellow and the malignancy colored green.

BCI Breast Cancer Eradication

BreastCancerInitiative (BCI) will be testing a new, patent-pending technology for eradication of breast cancer called Electrical Resonant Destruction. One of the bioelectrical tissue characteristics obtained as part of BCI cancer detection is tissue electrical resonant frequency. Energy applied to a structure at its resonant frequency will cause it to vibrate increasingly then uncontrollably if the applied energy is large enough. Since cell membranes have oppositely charged inner and outer surfaces, an alternating electric current will cause stress displacement of the membrane.

For cancer eradication, sufficient electrical energy is delivered via breast electrodes at the resonant frequency of the cancerous tissue to make membrane stress oscillations increase until cellular destruction occurs. The electrodes selected are those which bioimpedance measurement showed changes indicative of malignancy in the breast tissue underlying them.

Benefits of the New Technology

For Breast Cancer Screening
•Pain-free, no breast compression.
•Safe, no radiation.
•Results are automatic and immediate—No waiting.
•Convenience—The test can be performed in the family doctor’s office during an annual checkup.

For Breast Cancer Treatment
•Cell destruction is limited to the diseased area of the breast.
•Unlike chemotherapy, there is no spread of toxicity to rapidly dividing cells, e.g. in the bone marrow and hair follicles
•Treatment is non-invasive, rapid, with no discomfort.
•Treatment is safe, there is no ionizing radiation.

Who Are We?

BreastCancerInitiative.com is built around a core group of physicians, engineers, and programmers who have over 150 years of combined expertise in product development, manufacturing, clinical trials, and marketing in the high technology medical device field, including proven success in the use of bioimpedance for detection of breast cancer. Some of the more than 20 medical centers participating in our prior multinational clinical trial to assess the validity of bioimpedance for the detection of breast cancer are shown on the right.*

We have developed many ground-breaking medical devices in use throughout the world. All share the same attributes: they are based on proven biophysical principles and incorporate innovative engineering design. We are dedicated to the task of pursuing this new and promising direction for the detection and cure of breast cancer.


高頻低電流治腦癌及乳癌

Electric Fields Kill Tumors

A promising device uses electric fields to destroy cancer cells in the brain.
By Katherine Bourzac on August 8, 2007
.







Zapping tumors: Brain-cancer patients in a trial for a portable device that sends a weak electric field into the brain must wear electrodes almost constantly. One patient in a pilot clinical trial for the device, who still had cancer after radiation, chemotherapy, and surgery, experienced a complete recovery. The MRI at top shows a tumor on the left side of this patient’s brain before treatment. The MRI at bottom, taken after eight months of treatment, shows no tumor.

An Israeli company is conducting human tests for a device that uses weak electric fields to kill cancer cells but has no effect on normal cells. The device is in late-stage clinical trials in the United States and Europe for glioblastoma, a deadly brain cancer. It is also being tested in Europe for its effectiveness against breast cancer. In the lab and in animal testing, treatment with electric fields has killed cancer cells of every type tested.

The electric-field therapy was developed by Yoram Palti, a physiologist at the Technion-Israel Institute of Technology, in Haifa, who founded the company NovoCure to commercialize the treatment. Palti's electric fields cause dividing cancer cells to explode while having no significant impact on normal tissues. The range of electric fields generated by the device harms only dividing cells. And since normal cells divide at a much slower rate than cancer cells, the electric fields target cancer cells. "An Achilles' heel of cancer cells is that they have to divide," says Herbert Engelhard, chief of neuro-oncology in the department of neurosurgery at the University of Illinois, Chicago.






Even after chemotherapy, radiation therapy, and surgery, about 85 to 90 percent of glioblastoma patients' cancer still progresses, and their survival rates are low, says Engelhard. He has about 10 glioblastoma patients enrolled in the trial, which is testing the unusual treatment in patients for whom all other approaches have failed. Engelhard says that the results are encouraging but that it's too early to comment on the treatment's efficacy.

The electric fields' different effects on normal and dividing cells mostly have to do with geometry. A dividing cell has what Palti calls "an hourglass shape rather than a round shape." The electric field generated by the NovoCure device passes around and through round cells in a uniform fashion. But the narrow neck that pinches in at the center of a dividing cell acts like a lens, concentrating the electric field at this point. This non-uniform electric field wreaks havoc on dividing cells. The electric field tears apart important biological molecules, such as DNA and the structural proteins that pull the chromosomes into place during cell division. Dividing cells simply "disintegrate," says Palti.


Multimedia
•View an image and graphic of the device.

Palti, who for years has been studying the effect of electric fields on cancer and normal cells, says that he has verified this mechanism in computer models and experiments in the lab. "The physics are solid," says David Cohen, associate professor of radiology at Harvard Medical School.

Patients in the glioblastoma clinical trial wear the device almost constantly, carrying necessary components in a briefcase. A wire emerging from the briefcase connects to adhesive electrodes covering the skull. Alternating electric fields pass through the scalp, into the skull, and on to the brain. The Food and Drug Administration approved the device for late-stage clinical trials for glioblastoma following promising results from a pilot study in 10 patients, one of whom had a complete recovery.
http://www.pnas.org/content/104/24/10152.full

轉載Curezone
Science magazine #130, 1959, Humphrey and Seal
Biophysical Approach Toward Tumor Regression In Mice
Mice were given implants of sarcoma-180 tumors. Two external electrodes were placed on the skin, one over the tumor area. 3mA of direct current was applied for 4.8 hours daily, alternating hours between treatment and non-treatment so that total time was almost 9 hours. After 15 days the treated tumors were 58% smaller than the tumors in the control group. "By the 21st day all control animals had died and a 60 percent total regression of the test tumors had occurred. (Total regression means that the tumor had decreased progressively in volume, hardened, and dropped off, leaving a new skin surface at the former tumor site.)"

Medical Hypotheses (1997) 49, pg 297-300
Targeting a key enzyme in cell growth: A novel therapy for cancer
This study hypothesizes that the successes of studies of direct electrical current (DC) against cancer tumors is due to the fact that DC inhibits the RR enzyme which is necessary for cancer cell growth. The paper reviews other studies that had, amongst others, these results; 1) 60% of the treated mice had their tumors decrease/harden/drop-off using external electrodes at 3mA current for 4.8 hours daily for 21 days, 2) 88% tumor destruction in hamsters using one external electrode and one implanted needle electrode at 3mA for 1 hour daily for 4 days, 3) 98% average reduction in tumor size in hamsters using one external electrode and one implanted needle electrode at 2.4mA for 1 hour daily for 5 days.

Alternative Cancer Treatment with few side effects: The Electro Carcinoma Therapy (ECT)
This is information from the German clinic which references a 30% success rate (of total tumor destruction) that the Chinese had with over 10,000 patients. An additional 40% had reduction of tumor size. They applied the DC current to platinum wire electrodes, in the form of needles, injected directly into the tumors. In contrast; the German Marburg Institute works almost exclusively with metal electrode plates applied to the skin which gives them the same results. Their treatments are for 2-3 hours for at least 2 consecutive days. They vary the current amount according to tumor size and density.

高頻治癌

Holt Clinic
261 Stirlling Highway
Claremont
Western Australia 6910

Tel: +61 (0)8 9285 4000
Fax +61 (0)8 9285 4090

http://www.drholtsupport.com
http://www.the-institute.com.au

Documentation : http://www.rife.de/holts_documentation.html


--------------------------------------------------------------------------------

http://www.drholtsupport.com/simple.asp

A Simple Explanation

Treating cancer by ultra high frequency waves.

Cancer - Three features uniquely define cancer.

1 - It grows exponentially. That means every cell is dividing all the time. One cancer cell divides into two, then into four, then into eight, 16, 32 etc etc.
2 - It is irreversible.
3 - It passes on these traits from generation to generation.

Glucose

This sugar is used for three purposes. Firstly it provides energy from converting glucose into lactic acid for cancer cells to divide, without using oxygen. Secondly glucose uses oxygen and provides all the energy for your brain to function. Thirdly glucose with oxygen controls normal cell division. Cancer is a fault in this control which makes it cancerous.

434 MHz Ultra High Frequency Radiowaves

I discovered in 1973 that this frequency (used throughout the continent of Europe as the standard frequency for medical purposes) will temporarily activate cancer's burning of glucose without oxygen for between 20 and 30 minutes. Millions of patients throughout Europe have been treated since 1948 with this frequency for stimulating the repair of injuries, fractures, wound healing etc without any side effects being discovered. It stimulates normal cell division which is self limiting when repair is complete.

If the cancer cells' uptake of glucose from the blood can be blocked before applying UHF radiation the cancer cell will die. This is selective killing because it ONLY acts on the Glucose to Lactic Acid system.

The Treatment Method

Intravenous injection of glucose blocking agents immediately before UHF are essential and have to be given quickly through a vein or an intravenous line. The blocking agents consist of cystine and oxidised glutathione and other similar forms of amino acids in their fully oxidised state. They carry a lot of oxygen with them, they look like glucose to the cancer cell and are therefore rapidly absorbed by them immediately the UHF radiation commences. The glucose is “burnt” by the blocking agent's oxygen and the cancer cell dies.

Large arm veins are the most suitable site for injection. The smaller veins of the hand are unsuitable. The injection is slightly irritant and is approximately 50 ml of fluid. Before treatment starts a PICC line (Per Intravenous Cutaneous Catheter) can be inserted if the patient has poor veins. The line is inserted by a radiologist using ultrasound placement into a deep vein in the upper arm and can only be done in Perth if the patient has private health insurance. At the end of treatment the PICC line can be easily removed.

Results have come from 15 treatments over three weeks, Monday to Friday - 15 working days (remember WA's public holidays!).

The infusion of the glucose blocking agent takes approximately fifteen minutes and is immediately followed by 20 to 25 minutes of UHF therapy using the radiowave machine to part or all of the body.

Complications of Treatment

434 MHz UHF creates resonance (it shakes cancer cells like a bell) and fluorescence (the cancer re-radiates different frequencies) and the energy does create some heat in the normal cells similar to sitting in front of a large electric fire. It must be emphasised that this is not heat treatment and MUST NOT be called hyperthermia where the body is deliberately raised to 41.8°C by non electrical methods. After treatment half an hour's rest on a relaxing chair/bed under a fan allows the patient to drive their car away if they wish.

Side Effects

Every patient has their haematology, biochemistry and proof of cancer levels etc estimated before and after treatment. The only contraindication to treatment is a rare disease called thalassaemia because the red blood corpuscles in this disease (there are a few lesser variants which also may cause trouble) are readily damaged by mild warming (body temperature never exceeds 39.5°C, upper limit of human tolerance is 41.8°C) and the patients become anaemic. This may need fairly urgent transfusion if it occurs.

Approximately 1% or 2% of patients slight symptoms of the brain being starved of glucose may occur. The cancer obtains its glucose supply using the amino acid cysteine but the brain extracts its glucose using the amino acid methionine. This rare complication can be completely avoided by eating 100 to 200 grams of cooked red meat five times a week. If you are not willing to eat red meat during treatment there is 1 in 50 chance that you will experience these side effects and require admission to hospital. Patients must understand that if they do not eat red meat that treatment is at their own risk and that they must bear all consequences thereof.

No patient will be treated who is taking any antioxidant other than that which is contained in a normal, simple diet. For example large doses of Vitamin A, Vitamin C, Vitamin E, selenium and multiple other so-called anti-cancer antioxidants may result in ineffective treatment simply because these substances destroy the glucose blocking agents before they reach the cancer cell.

General Features for Successful Treatment

A: The smaller the individual lesions the better the result because as cancer masses become bigger so the blood supply to the centre decreases and the drug cannot penetrate there.
B: The total mass of cancer is important. Any estimated load in excess of 100 grams will probably require more than one session of treatment.

The Practical Regime

I treat every patient whom I consider have a chance of response with 15 days of treatment. Then wait six to eight weeks and reassess the situation. If there is significant improvement - decrease by 10-20% of the cancer mass - then retreatment should be carried out because cure is possible in such patients. The maximum number of treatment courses given was seven in a patient with mesothelioma treated twelve years ago who now is alive and well without evidence of the disease.

Specific Contraindications to Treatment

1. A major contraindication to UHF therapy is having had any form of chemotherapy (also called cytotoxics, or cytotoxic treatment). These drugs are non-specific cell poisons designed to act against the genetic material in the cell nucleus. They do not act specifically on the cause of cancer, which is damage in the cytoplasm or extra-nuclear part of the cell. Normal cells are designed and controlled perfection using genetic information. Cancer is caused by irreparable damage to the system which interprets our genetic “blueprint”. It is pointless to destroy genes when their instructions are ignored by a defective system.

Some cytotoxic drugs may make normal cells more conductive to electricity so that there is little electrical difference between cancer cells and normal cells and then UHF no longer only acts on cancer cells.

2. Collections of fluid in the chest cavities, heart cavity or abdominal cavity must be drained and the cavities dry if satisfactory results are to be obtained in the underlying cancer. As examples - cancer of the lung and breast can cause outpourings of fluid in the left or right pleural space (cavity surrounding the lung) and more rarely in the pericardial (heart) space. UHF radiation will not penetrate collections of fluid. They may become hot enough to increase the damage in the cavities.

Fluid in the peritoneal cavity is called ascites. This is a common accompaniment of ovarian cancer and partial blockage to the lymphatics draining the abdominal cavity and occasionally due to obstruction in the liver from secondary cancer in that organ. Ascites may also get worse after UHF treatment and may prevent the underlying cancer receiving any effective UHF dosage. Ascites, pleural and/or pericardial collections of fluid are best treated by aspiration and installation of appropriate substances so that the surfaces of the space are inflamed and stick together thus obliterating the space. The effusion must have been controlled completely by such measures before radiowave therapy is possible .

If patients arrive with collections of fluid and this minor operation has to be performed before or during treatment they will be referred for drainage by another doctor. Patients without private hospital insurance cover with this complication will be referred to a public hospital, if so requested.

3. Smoking is absolutely contraindicated to the treatment. Treatment must not be commenced until at least several weeks after smoking has ceased. The carbon monoxide in cigarette smoke may inactivate the oxygenating effect of the glucose blocking agent.

Further Information

Treatment is given only as out-patient attendance. Stretcher patients do not fit within the machine and wheel chair bound patients can only be treated if they are fairly mobile. Should any problem arise and a public hospital admission is essential, not only is Dr Holt unable to supervise you in such an institution but UHF therapy cannot be given whilst an in-patient in one.

All hospitals in WA require every interstate patient admitted to have a certificate from their local pathologist stating that they are free from MRSA (Methicillin Resistant Staphylococcus Aureus infection). To minimise cross infection in our own rooms the results of the MRSA test must be known to us before arriving for a course of therapy.

The treatment centre is in West Perth, an inner suburb with free bus travel to the city. Short term rental flats are available within a one to five kilometre radius. Your travel agent can arrange an hotel to start and then you can find your exact needs at leisure.

Costs

A three week course of treatment is a total of $6550 with a Medicare rebate (at 85% of the scheduled fee) of $2206.50 (as at 1 November 2003). The difference of $4343.50 must be paid during the first week of treatment.

Under the new Safety Net Medicare will now meet 80% of the out-of-pocket costs for medical services. Medicare may therefore give you a further rebate after the account for treatment has been processed by them.

Always make a claim from your State against your travel costs to WA (Patients’ Assisted Travel Scheme/Patient Transport Assistance Scheme). These forms are available from your local hospital.

Please note that we do not have the facilities to accept eftpos or credit card transactions. Payment can be made via cash or cheque.

If you do not have a referral from your GP or a specialist Medicare will not pay their portion of your account. Please ensure you bring one with you.

J A G Holt
M.B., Ch.B., F.R.C.S., F.R.C.R., F.R.A.C.R, D.M.R.T., D.R.C.O.G.

低交流電治攝護腺癌的動物實驗

Low dose, alternating electric current inhibits growth of prostate cancer.

Koreckij TD, Hill C, Azure L, Nguyen H, Kunz LL, Azure A, Corey E, Lange P, Vessella RL.


Source

Department of Urology, University of Washington, Seattle, Washington 98195, USA.


Abstract

BACKGROUND:

A number of minimally invasive technologies exist for the treatment of prostate cancer (CaP), each with their associated morbidities. We sought to test the efficacy of low dose alternating electric current (LDAEC) to inhibit CaP growth in a preclinical setting and determine its effect on normal tissue.

METHODS:

In the first study, two power settings, 15 or 25 mA of current, and two treatment times, 15 or 60 min, were evaluated in C4-2B CaP xenografts. In the second study, power was regulated to maintain an intra-tumoral temperature of
RESULTS:

The most effective tumor volume reduction in the first study was seen with tumors treated with 25 mA for 15 min (62 +/- 9.4% decrease, P = 0.001). Longer treatment time did not enhance treatment effect. Using 45 degrees C to govern delivery of LDAEC resulted in a near 100% reduction in tumor volume in 8/10 mice with C4-2B tumors (P < 0.001) with similar inhibition of LuCaP 35 tumors (P = 0.01). This treatment, although resulting in skeletal muscle necrosis, did not affect nerves, smooth muscle and blood vessels.

CONCLUSION:

LDAEC demonstrates efficacy against C4-2B and LuCaP 35 CaP xenografts while causing no harm to nerves and blood vessels. These results warrant further investigations into the use of LDAEC as a treatment for CaP.

(c) 2009 Wiley-Liss, Inc.

Radiowave, nanoparticles, and antibodies coating to cure cancer
The Kanzius Machine: A Cancer Cure?


聯合報／記者詹建富 2007/05/30

交大電子工程系教授李鎮宜指出，人類最初由物體間的摩擦，發現能夠產生靜電，在富蘭克林發明避雷針後，更進一步消除人類對於雷電的恐懼，甚至發電機的問世帶動了第二次工業革命。如今，現代人的生活周遭更充斥了各種電器電品，如果沒有電恐怕許多事情都將停擺。



至於最早把電應用於治療疾病，則可上溯到西元前四世紀。台大醫院復健科醫師林銘川表示，根據史書記載，當時希臘人和羅馬人發現一種電鰻可產生一百至一百五十伏特的電流，於是利用這種魚產生的電流來治療足部的關節炎。



台安醫院復健科主任鍾佩珍指出，人體可說是一個電磁場，包括神經及肌肉都有電生理特性，尤其電流進入人體內，神經感受最為敏感，因此在神經內科或復健科有許多肌電診斷檢查，包括神經傳導檢查、肌電圖檢查或誘發電位檢查等，便是以電流刺激神經並記錄運動、感覺的反應，作為神經、肌肉病變的輔助診斷工具。














疼痛病人接受電流刺激穴位，以緩解身體的不適或痠痛。（記者盧振昇／攝影）


目前，醫界用電能所產生的刺激，最主要用在減少疼痛，或避免、延緩肌肉萎縮，減輕肌肉痙攣和促進血液循環。鍾佩珍舉常見的肌肉、關節疼痛為例，最常用是以經皮神經電刺激器(TENS，中文名稱為「痛止」)，或以中頻干擾波 (IFC)透過脈衝電流，對肌肉及肌肉進行電刺激，提高對疼痛的耐受度，另一方面也影響或阻隔神經傳遞痛的感覺，進而降低疼痛，這即是疼痛的「門閥控制」理論。


另外，肌肉電刺激療法 (ES)則是讓中風或周邊神經損傷患者，用來避免肌肉萎縮。台北國泰醫院物理治療組長簡文仁舉顏面神經麻痺為例，這類病患如果沒有治療，容易造成臉部肌肉萎縮，導致嘴歪眼斜，給予肌肉電刺激可以代替暫時失去功能的神經，防止肌肉萎縮。



同樣的，脊髓損傷而喪失性功能的男性病患，醫師如今可用電刺激取精，再進行體外受精。而中老年婦女常見的尿失禁，臨床上也可針對會陰部肌肉給予電刺激，促使尿道括約肌收縮，用來訓練減少尿失禁的症狀。



值得一提的是，雖然人體觸電會有死亡之虞，但對於因心律不整而造成心臟震顫的病人，若能及時以心臟電擊器或自動體外心臟去顫器施予電擊，卻是可以救命，證明善用電，它可是人類的救星。



延伸閱讀



1.The Better Back Book(背痛輕百科)／Stella Weller著、洪世民譯／山岳文化
2.電機學／吳朗／全華圖書
3.鍾佩珍復健教室／鍾佩珍復健教室／原水出版


全文網址: 電療》電流 善用治病 亂用致命 - 新聞中的科學 - 文教要聞 - udn校園博覽會 http://mag.udn.com/mag/campus/storypage.jsp?f_ART_ID=71161#ixzz2DERJETdl
Power By udn.com

物理治療為何有效?


--電位治療器的機轉--


摘錄自富山醫科藥科大學田澤賢次教授之研究報導內容,由義守大學物理治療系系主 任廖文炫 博士整理


醫界有此一說:電位治療器或熱療對腰痛或肩頸僵硬酸痛有效。但到底次那些作用使物理治療有效呢?以下是執臨床研究多年牛耳之富山醫科藥科大學田澤賢次教授對此一機轉的說明:


電位治療器是由已故日本醫學博士原敏之先生於1928年首度發明的,其為一種交流高壓電治療器,利用電場或電場所產生的誘導電流作用來促進人體健康。


日本厚生勞動省認定此電位治療器具有緩解頭痛、肩頸肌肉僵硬酸痛、失眠、便秘等功效。對改善腰痛之效果也經過多項臨床實驗數據及研究報告證實有效。



將人體制餘7,000~30,000伏特的高壓電場或60Hz的極低周波時,人體表面會形成一個電場,誘導出人體內之微小電流。這些微小電流會促使血液中鈉離子及鈣離子增加,使體內的體液變為弱鹼性;也活化細胞的新陳代謝作用,進而提高人體的自然治癒能力。


對腰痛或肩頸僵硬酸痛為何有效則可從肌膜鈣離子之通道(channel)來解釋:為了改善肌肉僵硬痙攣現象,必須抑制肌肉細胞內過多的鈣離子,透過放鬆自主神經來達到緩和緊張之肌肉。根據我們的研究,電位治療不但可以讓濃稠混濁的血液變的較清澈外,也間接的增加肌肉的血液循環。


廖文炫博士表示,這些都可以透過固定使用HEALTHTRON 來獲得最佳改善效果。


田澤賢次 簡介


1940年2月13日於清森縣


日本人工肛門復健醫學會理事長/日本癌學評議員/日本消化器外科學會評議員/日本大腸肛門病學會評議員/日本人類細胞學會理事/日本生物理療學會理事/日本外科學會會員/美國癌學會會員/國際大學結腸直腸會議員


【主要著作】創傷管理與治癒系統


皮膚保護劑與人工肛門皮膚保養


癌轉移的診斷與治療


最新癌免疫化學療法之指針








高電位療法12問　　　　　　　　　　　　


問 1 誰發明高電位療法


答：高電位療法是美國科學家富蘭克林（Franklin）和生物學家一起根據電場和生物體離子之間的關係，作了大量的臨床研究而發明的。高電位治療儀是結合高壓電子技術和生理電子學的高科技產品。


問 2 什麼是高電位療法


答：高電位療法是利用高電壓低電流的高壓靜電場，對人體進行電調整作用，調節血液的酸鹼平衡（PH），抑制血液的酸性化，使酸性化的血液恢復正常的弱鹼化，從而促進新陳代謝，使失調病變的組織器官康復，達到治病和保健的作用。


問 3 高電位療法原理


答：A.人體血液同其它生物組織一樣，都是由各種帶電離子物質組成的，其中呈負電的陰離子佔多數，血液的PH值呈現為弱鹼性，而當帶正電的陽離子佔多數時，血液的PH值呈現為弱酸性，一般健康人的血液的PH值屬於弱鹼性。而不規則的生活、飲食、和過度緊張的人的血液呈現為弱酸性，血液的酸性化使人體各組織器官出現不良的反應，如疲勞、緊張、睡眠不足、神經衰弱、心腦血管疾病和癌症等。高壓靜電場可以產生有效的強電刺激，以增強細胞活力，調整神經系統，使肌體得到綜合有效的治療。


B.高電位治療器主要通過高壓靜電場對人體全身進行直接作用，通過高壓電子的力量，對人體血液中的蛋白質，膽固醇，中性脂肪，甘油三脂等成分進行高壓分解和中和，及通過高壓電子對人體的內臟神經進行刺激，從而達到淨化血液和調節植物神經的作用，將體內的垃圾通過大便，小便和發汗將其排出體外的一種全身性治療方法。從而從根本上對人體進行治療。


問 4 高電位療法作用與機制


答：高電位療法的作用機制，一般認為是通過輸出高電壓低電流形成的高壓靜電場，調節肌體的PH，抑制血液酸化（而血液的酸化可使肌體組織器官產生不良反應並導致疾病），使血液存回正常的弱鹼性，從而有利於疾病的康復。同時，有效的高電位刺激可增強細胞活力，調整神經系統功能，使肌體得到綜合有效的調理，且對局部有消炎止痛之功。故這一療法對慢性病有廣泛的適應症。


問 5 高電位療法作用


答：促進新陳代謝，調節植物神經，恢復腦細胞功能，改善心腦血管血液供應。促進血液循環，調節血管張力，降低血液粘稠度，防治動脈粥樣硬化，改善血清脂蛋白構成，降低高血壓等。


問 6 通則不痛


答：高電位治療器產生高於一萬伏，小於數百微安的，安全的高壓靜電場，正電子會不斷地往負電子流動，人體進入這個靜電場後，所有的循環系統都會被帶動循環（呼吸系統、血液系統、消化系統、生殖系統、泌尿系統、淋巴系統等），中醫說通則不痛，不通則痛。因此凡是由于不通引起的疾患都可得到治療和緩解。


問 7 高電位療法適應症


答：失眠，神經衰弱，腸胃不調，食慾不振，便祕，痔瘡，皮膚瘙癢，風濕性疾病、關節炎，頸椎病，腰腿痛，跌打損傷，軟組織損傷，骨傷，頭暈耳鳴，前列腺肥大，貧血，高血壓，高血脂，糖尿病，腦震盪後遺症，各種缺血性疾病、更年期綜合症，恢復疲勞等。


問 8 高電位療法禁忌症


答：攜帶心律調整器者，心肺腎功能嚴重衰竭者，惡性腫瘤末期，急性傳感病發作期，各種出血性疾病，發高燒，婦女妊娠期，心臟病手術後恢復期等。


問 9 高電位療法為什麼適應症很多


答：因為所有的循環系統都會被帶動循環，中醫說通則不痛，不通則痛。許多疾患都是不通引起的，因此，高電位治療法還有尋找身體不通部位的作用。


問 10 高電位療法並不適用於所有的疾病


答：高電位治療器不是治百病的，有些疾病更是禁忌的，請注意禁忌症範圍！高電位治療器對其適應症範圍內的疾病的治癒率也是有不同的百分比的。


問 11 高電位療法使用中特別的注意事項


答：1·初次接受治療的人，如遇頭暈或心跳過快，應暫時中止治療。


2·個別出現局部皮膚蟻爬感，癢，酸，麻，輕度刺疼等，均屬正


常症狀。


問12.高電位治療器與藥物的不同。


答：高電位治療器與藥物有著根本的不同,主要反映在以下幾個方


面：


1·副作用問題：使用高電位治療器沒有任何副作用，而使用藥物治療會產生大大小小的副作用。


2·治療方法問題：高電位治療器屬於全身性療法，從身體內部對人體進行調節和治療，從而達到淨化血液，調節自律神經的作用；而藥物屬於局部療法和對症療法，僅僅對病症或是症狀的某一部位進行抑制作用，無法達到治療的作用。


3·使用結果的問題：使用高電位治療器，可以通過對疾病和症狀進行兩步調整的方法。先是治療，其次是預防。從而達到對預防疾病和提高人體自然治癒能力方面的結果是最大的。而藥物只是控制，造成疾病被暫時壓抑，從而影響治療的時機。


4·依賴性的問題：使用高電位治療器不會產生依賴性，是一種良好的習慣。正如同每天刷牙一樣，每天的健康可以通過使用高電位治療儀得以維持，而使用藥物會產生依賴的結果。導致於終生服藥的現象發生。


總之，人體是不需要藥物的。經常使用藥物的人，身體就會變成一個依賴藥物的身體，從而導致病變的發生。


☆藥物即毒物!! 全世界的藥理學院院長都一致說——藥物即毒物。


▲用藥如用兵：俗話說"藥物即毒物"，無論中西藥物"是藥三分毒，無毒不成藥"藥可治病，也可致病"。患者用藥往往只關心藥品療效，忽視其具有毒性副作用，輕則無效，重則中毒，因而導致"藥物致癌""藥物傷肝腎""藥物誘發癲癇"

TENS

　對於患有長期痛症人士，除服用止痛藥減輕疼痛外，還可選擇其他治療方式，例如透皮神經電刺激（TENS），便為另一療法。此法利用一個使用乾電池的小型醫療儀器，透過釋出特定的微電流，用以紓緩疼痛。治療時物理治療師會將兩個或更多的電極貼片，貼在疼痛點或神經分布的部位，然後啟動電刺激器，讓電流通過該部位，產生電刺激作用，並因應患者的病情及患處等，調整電流的波長、頻率及電流強度。
　　一般的電流強度都不會太強，以能達到紓緩疼痛效果及於能忍受的範圍內作考慮。如果電流太強，不但起不到治療作用，甚至有可能燒傷皮膚，令炎症加劇，因此必須由專業人士進行治療，減低受傷風險。儀器釋出的微電流可刺激表皮神經產生感覺訊號，用以干擾及抑制原本的疼痛訊息，減少疼痛訊息傳遞至腦部，藉此緩和各類的肌肉疼痛。其次，微電流亦可以刺激腦部自行分泌具有止痛效果的化學物質胺多芬，有助鎮痛。

再談神奇的氯化鎂 - The Elixir?

看哪,現今我八十五歲了.我還是強壯像摩西打發我去的那天一樣.無論是爭戰,是出入,我的力量那時如何,現今還是如何. 迦勒, 約書亞十四章,10-11

各位朋友,在追求長生的過程中,要知道身体若不健康久活是一種痛苦.死也不那麼可怕,生而無趣不如早早死亡的好.而生要有趣首先要活的有意思,要能愛己愛人.而要愛己愛人首先一定要身体健康.迦勒八十五歲猶如四十歲的秘密在那裡呢?秦始皇求不死的仙丹到底在那裡呢?

我訂的Carolyn Dean 的 The magnesium Miracle終於來了我也仔細看完了,我服用氯化鎂也超過一個月了,我的感覺是真的物超所值,滿意極了.
1. 不再抽筋.這是我服用氯化鎂的主要目的.目的百分百達成當然高興.
2. 睡眠較好.這是安神的副作用,不客氣的收下了.
3. 鼻子過敏也好很多,是一种自然的antihistamine.我當然高興.
4. 看來手腳冰冷也改善很多.但冬天還沒到,不敢高興太早.

唯一美中不足的是攝護腺疼痛及夜間排尿的改善尚不見持續性的改善.我的意思是有時還會有不良的情形發生.像我昨晚去朋友家吃飯昨晚就有奇怪不適的感覺.

未完